NEW-ONSET ATRIAL FIBRILLATION FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT: INCIDENCE, ANTICOAGULANT STRATEGY, AND OUTCOMES

Background: Pre-procedure atrial fibrillation (AF) has been associated with adverse outcomes in patients undergoing TAVR, but the incidence of new-onset AF and related anticoagulant management and outcomes is unclear. Methods: Using the STS/ACC TVT Registry linked with Medicare data we evaluated